August 27, 2012 (Munich, Germany) — Use of an intra-aortic balloon pump (IABP) offered no mortality benefits at 30 days in the 600-patient IABP SHOCK II trial, according to Dr Holger Thiele ...

The Global Intra-Aortic Balloon Pump (IABP) market study provides critical information related to the global, regional and top players including Intra-Aortic Balloon Pump (IABP) market share analysis, ...

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...

MUNICH, Germany—Although use of an intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock appears safe, the technique does not improve ...

Intra-aortic balloon pump (IABP) therapy increases bleeding and in-hospital mortality when used during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) or those ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...

Teleflex announced FDA clearance for an intra-aortic balloon pump for the treatment of patients with severe arrhythmias or heart rates up to 200 beats per minute, including those who were originally ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

The Global Intra-Aortic Balloon Pump (IABP) Market Research Report 2021-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced it has designated a recall of intra-aortic balloon pumps by Datascope/Getinge as class I, the ...